Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2024European Heart Journal SupplementsOpen Access

Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: assessing net clinical benefit

View Full Paper
Ask AI
Bookmark
Share

Authors

WMWilliam F. McIntyreABAlexander P. BenzNTNedim Tojaga

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

McIntyre et al. (2024) studied this question.

synapsesocial.com/papers/68e6249ab6db6435875b6873https://doi.org/10.1093/eurheartjsupp/suae075
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Discrepant Outcomes of Direct Oral Anticoagulant Trials in Device-Detected Atrial Fibrillation after Stroke: Insights from NOAH-AFNET 6 and ARTESIA2026
  2. 2Abstract TP116: Comparative Effectiveness of Direct Oral Anticoagulants Among Patients with Clinical Versus Subclinical Atrial Fibrillation: A Systematic Review and Meta-analysis of Randomized Controlled Trials2026
  3. 3Direct-Acting Oral Anticoagulants in Atrial Fibrillation2020 · 9 citations
  4. 4Comparison of Oral Anticoagulants vs. Warfarin for Stroke Prevention in Atrial Fibrillation: A Meta-Analysis2024
  5. 5Efficacy and safety of direct oral anticoagulants in patients with device-detected atrial fibrillation with and without dose reduction criteria: a pooled analysis of ARTESiA and NOAH-AFNET 62025